Maxime Dewolf

Maxime Dewolf

Auto-generated profile, based on publicly available information

Maxime Dewolf

Centre Hospitalier Universitaire de Reims, Service de Pneumologie, Reims, France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
JPJeanne-Marie Perotin
Jeanne-Marie Perotin
CLClaire Launois
Claire Launois
MDMaxime Dewolf
Maxime Dewolf
ADAntoine Dumazet
Antoine Dumazet
SDSandra Dury
Sandra Dury
GDGaetan Deslee
Gaetan Deslee
Chronic cough is a common complaint and a frequent cause of medical consultation. Its management can be difficult. We present here an overview of the current guidelines for the management of chronic cough. Different steps are detailed, including the initial research of an obvious etiology and alert signs that should lead to further investigation of underlying condition. The diagnosis of the most frequent causes: asthma, non-asthmatic eosinophilic bronchitis, gastroesophageal reflux disease and upper airway cough syndrome should be considered, assessed and treated accordingly. Recent advances have been made in the comprehension of refractory chronic cough pathophysiology as well as its pharmacologic and non-pharmacologic treatment, especially speech pathology therapy.

19 April 2024 in JMIR Medical Informatics
Verified
Journal Article
Open access
TRThéo Ryffel
Théo Ryffel
PCPerrine Créquit
Perrine Créquit
MBMaëlle Baillet
Maëlle Baillet
JPJason Paumier
Jason Paumier
YMYasmine Marfoq
Yasmine Marfoq
JCJacek Chmiel
Jacek Chmiel
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Federated analytics in healthcare allows researchers to perform statistical queries on remote data sets without access to the raw data. This method arose from the need to perform statistical analysis on larger datasets collected at multiple healthcare centers while avoiding regulatory, governance, and privacy issues that might arise if raw data were collected at a central location outside the healthcare centers. Despite some pioneering work, federated analytics is still not widely used on real-world data, and to our knowledge, no real-world study has yet combined it with other privacy-enhancing techniques such as differential privacy.federated analysis, differential privacy, real-world oncology study, non-small cell lung cancer, COVID-19federated analysis, differential privacy, real-world oncology study, non-small cell lung cancer, COVID-19 Objective: The first objective of this study was to deploy a federated architecture in a real-world setting. The oncology study used for this deployment compared the medical healthcare management of patients with metastatic non-small cell lung cancer before and during/after the 1st wave of COVID-19. The second goal was to test differential privacy in this real-world scenario to assess its practicality and utility as a privacy enhancing technology. Methods: A federated architecture platform was set up in the Toulouse, Reims and Foch centers. After harmonization of the data in each center, statistical analyses were performed using DataSHIELD, a federated analysis R library and a new open source differential privacy DataSHIELD package was implemented: dsPrivacy. Results: 50 patients were enrolled in the Toulouse and Reims centers and 49 in the Foch center. We have shown that DataSHIELD is a practical tool to efficiently conduct our study across all 3 centers without exposing data on a central node, once sufficient setup has been made to configure a secure network between hospitals. All planned aggregated results were successfully generated. We also observed that differential privacy can be implemented in practice with promising trade-offs between privacy and accuracy, and we built a library that will prove useful for future work. Conclusions: The federated architecture platform enabled a multicenter study to be conducted on real-world oncology data with strong privacy guarantees thanks to differential privacy.

1 January 2020 in Revue des Maladies Respiratoires Actualités
Verified
Journal Article
Closed access
Julien AncelJulien Ancel
Julien Ancel
RBRanda Belgacemi
Randa Belgacemi
ZDZ. Diabasana
Z. Diabasana
MDM. Dewolf
M. Dewolf
ABA. Bonnomet
A. Bonnomet
valérian dormoyvalérian dormoy
valérian dormoy